Circulating Wnt inhibitory factor 1 levels are associated with development of cardiovascular disease.
Ress C, Paulweber M, Goebel G, Willeit K, Rufinatscha K, Strobl A, Salzmann K, Kedenko L, Tschoner A, Staudacher G, Iglseder B, Tilg H, Paulweber B, Kaser S.
Ress C, et al. Among authors: iglseder b.
Atherosclerosis. 2018 Jun;273:1-7. doi: 10.1016/j.atherosclerosis.2018.03.045. Epub 2018 Mar 29.
Atherosclerosis. 2018.
PMID: 29649633